In a renewed push to stop the nationwide mailing of abortion medication, Susan B. Anthony Pro‑Life America called on the Department of Justice to settle the Louisiana v. FDA lawsuit before the September 9 hearing. The appeal follows a recent U.S. Senate report that highlighted what the organization describes as dangerous practices by abortion‑drug manufacturers.
Pro‑life leaders cite Senate findings
Marjorie Dannenfelser, president of the pro‑life group, told The Center Square that Senator Bill Cassidy’s research shows the current system allows drugs such as mifepristone to be shipped through the mail at all stages of pregnancy, including the third trimester in states like North Carolina. She added that the Charlotte Lozier Institute’s analysis found 81% of online abortion providers send the drug beyond the FDA’s 10‑week limit, putting women at risk of serious complications.
Call for DOJ action
Dannenfelser urged Attorney General Todd Blanche to protect women and save an estimated 15,000 unborn children each month by reaching a consent decree with Louisiana. She argued that a settlement would immediately halt mail‑order shipments while the FDA completes its safety review of mifepristone.
According to the organization, the existing mail‑order policy enables “abusers and exes” to obtain the drugs online without any medical screening or doctor involvement, leading to cases of poisoning and coercion across the nation. “It’s reckless and unsafe,” Dannenfelser said.
Senate report on drug manufacturers
Senator Cassidy, who chairs the Senate Health, Education, Labor, and Pensions (HELP) Committee, released a report this week detailing what the pro‑life group calls “dangerous practices” by abortion‑drug manufacturers. The report claims the companies fail to properly oversee prescription and distribution, and that their Risk Evaluation and Mitigation Strategies (REMS) are not being upheld, especially in online sales.
Cassidy’s statement warned that the lack of oversight puts mothers at risk, noting that manufacturers often rely on a cursory form without meaningful follow‑up or audits of prescribers.
Broader pro‑life coalition pressure
In July, Dannenfelser said that 83 pro‑life organizations, led by Susan B. Anthony Pro‑Life America, urged the Attorney General to resolve the case with a consent decree that stops mail‑order shipments now. The coalition also highlighted letters from women harmed by the drugs, who asked the DOJ to intervene.
The Department of Justice has not yet responded to requests for comment from The Center Square or the pro‑life coalition.
Legal background
Louisiana v. FDA stems from a lawsuit filed by the state of Louisiana challenging a Biden‑era rule that permits abortion medication to be mailed without an in‑person doctor visit. The case is set to resume on September 9, and a settlement could have immediate national implications for how abortion medication is distributed.
Original reporting: KTBS 3 (Shreveport) — read the source article.
